Endometrial assessment of premenopausal women prior to uterine artery embolization: A cross sectional survey of Interventional Radiologists

Abstract

Uterine artery/fibroid embolization (UAE/UFE) is a minimally invasive treatment for symptomatic uterine fibroids and/or adenomyosis. The terms menorrhagia, metrorrhagia, and dysfunctional uterine bleeding have been abandoned by the International Federation of Gynaecology and Obstetrics (FIGO) due to confusion surrounding their use; in their place abnormal uterine bleeding (AUB) has been adopted. [1] Munro M.G. Critchley H.O.D. Fraser I.S. Committee tFMD. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynecol Obstet. 2018; 143: 393-408 Crossref PubMed Scopus (150) Google Scholar This is an overarching term to describe any symptomatic variation from normal menstruation incorporating prolonged menstrual bleeding (>8 days), heavy menstrual bleeding (HMB), and intermenstrual bleeding. Premenopausal AUB affects up to one third of women during their life and the risk of cancer in those who proceed to endometrial biopsy has been estimated at 0.33% (95% CI 0.23–0.48%), and 0.11% (95% CI 0.04–0.32) in the subset with HMB. [2] Pennant M.E. Mehta R. Moody P. et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017 Feb; 124 ([PubMed PMID: 27766759. Pubmed Central PMCID: PMC5297977. Epub 2016/10/22. eng]): 404-411 Crossref PubMed Scopus (41) Google Scholar